公开(公告)号：US20020146389A1

公开(公告)日：2002-10-10

申请号：US10080455

申请日：2002-02-22

Applicant: Genentech, Inc.

Inventor： Avi J. Ashkenazi ,  Kevin P. Baker ,  Paul J. Godowski ,  Austin L. Gurney ,  Melanie R. Mark ,  Scot A. Marsters ,  Robert M. Pitti

IPC: A61K038/19 ,  C07H021/04 ,  C12P021/02 ,  C12N005/06 ,  C07K014/525

CPC classification number: C07K14/525 ,  A61K38/00 ,  C07K2319/02

Abstract: A tumor necrosis factor homolog, identified as DNA19355, is provided. DNA19355 polypeptide has apoptotic activity in mammalian cancer cells and may be involved in proinflammatory responses. Nucleic acid molecules encoding DNA19355, chimeric molecules and antibodies to DNA19355 are also provided.

Abstract translation: 提供了鉴定为DNA19355的肿瘤坏死因子同源物。 DNA19355多肽在哺乳动物癌细胞中具有凋亡活性，可能参与促炎反应。 还提供了编码DNA19355的核酸分子，嵌合分子和DNA19355的抗体。

公开(公告)号：US20030191059A1

公开(公告)日：2003-10-09

申请号：US10223082

申请日：2002-08-16

Applicant: Genentech, Inc.

Inventor： Kevin P. Baker ,  Napoleone Ferrara ,  Hanspeter Gerber ,  Mary E. Gerritsen ,  Audrey Goddard ,  Paul J. Godowski ,  Austin L. Gurney ,  Kenneth J. Hillan ,  Scot A. Marsters ,  James Pan ,  Jean-Philippe F. Stephan ,  Colin K. Watanabe ,  P. Mickey Williams ,  William I. Wood ,  Weilan Ye

IPC: A61K038/17 ,  C12P021/02 ,  C12N005/06 ,  C07K014/47 ,  C07H021/04 ,  C12N009/00

CPC classification number: A61K38/17 ,  C07H21/04 ,  C07K14/435 ,  C07K14/47 ,  C12N5/06 ,  C12N9/00 ,  C12P21/02

Abstract: Compositions and methods are disclosed for stimulating or inhibiting angiogenesis and/or cardiovascularization in mammals, including humans. Pharmaceutical compositions are based on polypeptides or antagonists thereto that have been identified for one or more of these uses. Disorders that can be diagnosed, prevented, or treated by the compositions herein include trauma such as wounds, various cancers, and disorders of the vessels including atherosclerosis and cardiac hypertrophy. In addition, the present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

公开(公告)号：US20030175900A1

公开(公告)日：2003-09-18

申请号：US10211884

申请日：2002-08-02

Applicant: Genentech, Inc.

Inventor： Avi J. Ashkenazi ,  Audrey Goddard ,  Paul J. Godowski ,  Austin L. Gurney ,  Kenneth J. Hillan ,  Scot A. Marsters ,  James Pan ,  Robert M. Pitti ,  Margaret Ann Roy ,  Victoria Smith ,  Donna M. Stone ,  Colin K. Watanabe ,  William I. Wood

IPC: C12P021/04 ,  C07H021/04 ,  A61K039/395 ,  C12P021/02 ,  C12N005/06 ,  C07K016/40

CPC classification number: C07K16/30

Abstract: The invention concerns compositions and methods for the diagnosis and treatment of neoplastic cell growth and proliferation in mammals, including humans. The invention is based upon the identification of genes that are amplified in the genome of tumor cells. Such gene amplification is expected to be associated with the overexpression of the gene product as compared to normal cells of the same tissue type and contribute to tumorigenesis. Accordingly, the proteins encoded by the amplified genes are believed to be useful targets for the diagnosis and/or treatment (including prevention) of certain cancers, and may act as predictors of the prognosis of tumor treatment. The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

公开(公告)号：US20030170228A1

公开(公告)日：2003-09-11

申请号：US10210951

申请日：2002-08-02

Applicant: Genentech, Inc.

Inventor： Avi J. Ashkenazi ,  Audrey Goddard ,  Paul J. Godowski ,  Austin L. Gurney ,  Kenneth J. Hillan ,  Scot A. Marsters ,  James Pan ,  Robert M. Pitti ,  Margaret Ann Roy ,  Victoria Smith ,  Donna M. Stone ,  Colin K. Watanabe ,  William I. Wood

IPC: A61K039/395 ,  C12P021/04 ,  C12N005/16 ,  C12N005/06 ,  C07K016/40 ,  C07H021/04

CPC classification number: C07K16/30

Abstract: The invention concerns compositions and methods for the diagnosis and treatment of neoplastic cell growth and proliferation in mammals, including humans. The invention is based upon the identification of genes that are amplified in the genome of tumor cells. Such gene amplification is expected to be associated with the overexpression of the gene product as compared to normal cells of the same tissue type and contribute to tumorigenesis. Accordingly, the proteins encoded by the amplified genes are believed to be useful targets for the diagnosis and/or treatment (including prevention) of certain cancers, and may act as predictors of the prognosis of tumor treatment. The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

公开(公告)号：US20030105012A1

公开(公告)日：2003-06-05

申请号：US10223088

申请日：2002-08-16

Applicant: Genentech, Inc.

Inventor： Kevin P. Baker ,  Napoleone Ferrara ,  Hanspeter Gerber ,  Mary E. Gerritsen ,  Audrey Goddard ,  Paul J. Godowski ,  Austin L. Gurney ,  Kenneth J. Hillan ,  Scot A. Marsters ,  James Pan ,  Jean-Philippe F. Stephan ,  Colin K. Watanabe ,  P. Mickey Williams ,  William I. Wood ,  Weilan Ye

IPC: C12P021/02 ,  C12N005/06 ,  C07K014/435 ,  A61K038/17 ,  C07H021/04 ,  C12N009/00

CPC classification number: A61K38/17 ,  C07H21/04 ,  C07K14/435 ,  C07K14/47 ,  C12N5/06 ,  C12N9/00 ,  C12P21/02 ,  Y02A50/473

Abstract: Compositions and methods are disclosed for stimulating or inhibiting angiogenesis and/or cardiovascularization in mammals, including humans. Pharmaceutical compositions are based on polypeptides or antagonists thereto that have been identified for one or more of these uses. Disorders that can be diagnosed, prevented, or treated by the compositions herein include trauma such as wounds, various cancers, and disorders of the vessels including atherosclerosis and cardiac hypertrophy. In addition, the present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

公开(公告)号：US20030105011A1

公开(公告)日：2003-06-05

申请号：US10223084

申请日：2002-08-16

Applicant: Genentech, Inc.

Inventor： Kevin P. Baker ,  Napoleone Ferrara ,  Hanspeter Gerber ,  Mary E. Gerritsen ,  Audrey Goddard ,  Paul J. Godowski ,  Austin L. Gurney ,  Kenneth J. Hillan ,  Scot A. Marsters ,  James Pan ,  Jean-Philippe F. Stephan ,  Colin K. Watanabe ,  P. Mickey Williams ,  William I. Wood ,  Weilan Ye

IPC: A61K038/17 ,  C07K014/435 ,  C12P021/02 ,  C12N005/06 ,  C07H021/04 ,  C12N009/00

CPC classification number: A61K38/17 ,  C07H21/04 ,  C07K14/435 ,  C07K14/47 ,  C12N5/06 ,  C12N9/00 ,  C12P21/02 ,  Y02A50/473

Abstract: Compositions and methods are disclosed for stimulating or inhibiting angiogenesis and/or cardiovascularization in mammals, including humans. Pharmaceutical compositions are based on polypeptides or antagonists thereto that have been identified for one or more of these uses. Disorders that can be diagnosed, prevented, or treated by the compositions herein include trauma such as wounds, various cancers, and disorders of the vessels including atherosclerosis and cardiac hypertrophy. In addition, the present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

公开(公告)号：US20030100497A1

公开(公告)日：2003-05-29

申请号：US10223085

申请日：2002-08-16

Applicant: Genentech, Inc.

Inventor： Kevin P. Baker ,  Napoleone Ferrara ,  Hanspeter Gerber ,  Mary E. Gerritsen ,  Audrey Goddard ,  Paul J. Godowski ,  Austin L. Gurney ,  Kenneth J. Hillan ,  Scot A. Marsters ,  James Pan ,  Jean-Philippe F. Stephan ,  Colin K. Watanabe ,  P. Mickey Williams ,  William I. Wood ,  Weilan Ye

IPC: A61K038/17 ,  C07K014/435 ,  C12P021/02 ,  C12N005/06 ,  C07H021/04 ,  C12N009/00

CPC classification number: A61K38/17 ,  C07H21/04 ,  C07K14/435 ,  C07K14/47 ,  C12N5/06 ,  C12N9/00 ,  C12P21/02

Abstract: Compositions and methods are disclosed for stimulating or inhibiting angiogenesis and/or cardiovascularization in mammals, including humans. Pharmaceutical compositions are based on polypeptides or antagonists thereto that have been identified for one or more of these uses. Disorders that can be diagnosed, prevented, or treated by the compositions herein include trauma such as wounds, various cancers, and disorders of the vessels including atherosclerosis and cardiac hypertrophy. In addition, the present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.